These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Endothelial dysfunction--an obstacle of therapeutic angiogenesis. Sun L; Bai Y; Du G Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I. Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806 [TBL] [Abstract][Full Text] [Related]
6. Angiogenesis for the treatment of vascular diseases. Chawla PS; Keelan MH; Kipshidze N Int Angiol; 1999 Sep; 18(3):185-92. PubMed ID: 10688416 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic angiogenesis: a case for targeted, regulated gene delivery. Webster KA Crit Rev Eukaryot Gene Expr; 2000; 10(2):113-25. PubMed ID: 11186327 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--Part II. Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M Cardiol Rev; 2008; 16(5):219-29. PubMed ID: 18708823 [TBL] [Abstract][Full Text] [Related]
9. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation? Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208 [TBL] [Abstract][Full Text] [Related]
10. Growth factors for therapeutic angiogenesis in peripheral arterial disease. Jones WS; Annex BH Curr Opin Cardiol; 2007 Sep; 22(5):458-63. PubMed ID: 17762548 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic angiogenesis for ischemic diseases]. Aoki M; Morishita R Nihon Rinsho; 2006 Apr; 64(4):762-8. PubMed ID: 16613196 [TBL] [Abstract][Full Text] [Related]
12. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease. Shah PB; Losordo DW Adv Genet; 2005; 54():339-61. PubMed ID: 16096018 [TBL] [Abstract][Full Text] [Related]
13. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs. Silvestre JS; Kamsu-Kom N; Clergue M; Duriez M; Lévy BI J Pharmacol Exp Ther; 2002 Dec; 303(3):1038-43. PubMed ID: 12438525 [TBL] [Abstract][Full Text] [Related]
14. Multi-scale computational models of pro-angiogenic treatments in peripheral arterial disease. Mac Gabhann F; Ji JW; Popel AS Ann Biomed Eng; 2007 Jun; 35(6):982-94. PubMed ID: 17436110 [TBL] [Abstract][Full Text] [Related]
15. Human FGF-1 gene transfer promotes the formation of collateral vessels and arterioles in ischemic muscles of hypercholesterolemic hamsters. Caron A; Michelet S; Caron A; Sordello S; Ivanov MA; Delaère P; Branellec D; Schwartz B; Emmanuel F J Gene Med; 2004 Sep; 6(9):1033-45. PubMed ID: 15352076 [TBL] [Abstract][Full Text] [Related]
16. Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia. Rissanen TT; Rutanen J; Ylä-Herttuala S Adv Genet; 2004; 52():117-64. PubMed ID: 15522734 [TBL] [Abstract][Full Text] [Related]